There are only a few antifungal drugs used systemically in treatment, and invasive fungal infections that are resistant to these drugs are an emerging problem in health care. In this study, we performed a high-copy-number genomic DNA (gDNA) library screening to find and characterize genes that reduce susceptibility to amphotericin B, caspofungin, and voriconazole in Saccharomyces cerevisiae We identified the PDR16 and PMP3 genes for amphotericin B, the RMD9 and SWH1 genes for caspofungin, and the MRS3 and TRI1 genes for voriconazole. The deletion mutants for PDR16 and PMP3 were drug susceptible, but the other mutants had no apparent susceptibility. Quantitative-PCR analyses suggested that the corresponding drugs upregulated expression of the PDR16, PMP3, SWH1, and MRS3 genes. To further characterize these genes, we also profiled the global expression patterns of the cells after treatment with the antifungals and determined the genes and paths that were up- or downregulated. We also cloned Candida albicans homologs of the PDR16, PMP3, MRS3, and TRI1 genes and expressed them in S. cerevisiae Heterologous expression of Candida homologs also provided reduced drug susceptibility to the budding yeast cells. Our analyses suggest the involvement of new genes in antifungal drug resistance.

Department of Medical Biology and Genetics School of Medicine Inonu University Malatya Turkey

Department of Molecular Biology and Genetics Izmir Institute of Technology Urla Izmir Turkey

Institute of Physiology Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Bow EJ, Loewen R, Cheang MS, Schacter B. 1995. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin Infect Dis 21:361–369. doi:10.1093/clinids/21.2.361. PubMed DOI

George MJ, Snydman DR, Werner BG, Griffith J, Falagas ME, Dougherty NN, Rubin RH, Boston Center for Liver Transplantation CMVIG-Study Group, Cytogam, MedImmune, Inc. Gaithersburg, Maryland. 1997. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Am J Med 103:106–113. doi:10.1016/S0002-9343(97)80021-6. PubMed DOI

De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy, Infectious Diseases Mycoses Study Group Consensus Group. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821. doi:10.1086/588660. PubMed DOI PMC

Cutler JE, Deepe GS Jr, Klein BS. 2007. Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol 5:13–28. doi:10.1038/nrmicro1537. PubMed DOI PMC

Lewis RE, Cahyame-Zuniga L, Leventakos K, Chamilos G, Ben-Ami R, Tamboli P, Tarrand J, Bodey GP, Luna M, Kontoyiannis DP. 2013. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses 56:638–645. doi:10.1111/myc.12081. PubMed DOI

Cohen BE. 2010. Amphotericin B membrane action: role for two types of ion channels in eliciting cell survival and lethal effects. J Membrane Biol 238:1–20. doi:10.1007/s00232-010-9313-y. PubMed DOI

Gray KC, Palacios DS, Dailey I, Endo MM, Uno BE, Wilcock BC, Burke MD. 2012. Amphotericin primarily kills yeast by simply binding ergosterol. Proc Natl Acad Sci U S A 109:2234–2239. doi:10.1073/pnas.1117280109. PubMed DOI PMC

Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE. 2004. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 351:1391–1402. doi:10.1056/NEJMoa040446. PubMed DOI

Letscher-Bru V, Herbrecht R. 2003. Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother 51:513–521. doi:10.1093/jac/dkg117. PubMed DOI

McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR Jr, Rinaldi MG. 1997. In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob Agents Chemother 41:1832–1834. doi:10.1128/AAC.41.8.1832. PubMed DOI PMC

Yu S, Chai X, Hu H, Yan Y, Guan Z, Zou Y, Sun Q, Wu Q. 2010. Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase. Eur J Med Chem 45:4435–4445. doi:10.1016/j.ejmech.2010.07.002. PubMed DOI

Zhang C, Milunsky JM, Newton S, Ko J, Zhao G, Maher TA, Tager-Flusberg H, Bolliger MF, Carter AS, Boucard AA, Powell CM, Sudhof TC. 2009. A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J Neurosci 29:10843–10854. doi:10.1523/JNEUROSCI.1248-09.2009. PubMed DOI PMC

Huang Z, Chen K, Zhang JH, Li YX, Wang H, Cui DD, Tang JW, Liu Y, Shi XM, Li W, Liu D, Chen R, Sucgang RS, Pan XW. 2013. A functional variomics tool for discovering drug-resistance genes and drug targets. Cell Rep 3:577–585. doi:10.1016/j.celrep.2013.01.019. PubMed DOI PMC

Bari VK, Sharma S, Alfatah M, Mondal AK, Ganesan K. 2015. Plasma membrane proteolipid 3 protein modulates amphotericin B resistance through sphingolipid biosynthetic pathway. Sci Rep 5:9685. doi:10.1038/srep09685. PubMed DOI PMC

Nouet C, Bourens M, Hlavacek O, Marsy S, Lemaire C, Dujardin G. 2007. Rmd9p controls the processing/stability of mitochondrial mRNAs and its overexpression compensates for a partial deficiency of oxa1p in Saccharomyces cerevisiae. Genetics 175:1105. doi:10.1534/genetics.106.063883. PubMed DOI PMC

Wang X, Kruglyak L. 2014. Genetic basis of haloperidol resistance in Saccharomyces cerevisiae is complex and dose dependent. PLoS Genet 10:e1004894. doi:10.1371/journal.pgen.1004894. PubMed DOI PMC

Froschauer EM, Schweyen RJ, Wiesenberger G. 2009. The yeast mitochondrial carrier proteins Mrs3p/Mrs4p mediate iron transport across the inner mitochondrial membrane. Biochim Biophys Acta 1788:1044–1050. doi:10.1016/j.bbamem.2009.03.004. PubMed DOI

Chen XL, Silver HR, Xiong L, Belichenko I, Adegite C, Johnson ES. 2007. Topoisomerase I-dependent viability loss in Saccharomyces cerevisiae mutants defective in both SUMO conjugation and DNA repair. Genetics 177:17–30. doi:10.1534/genetics.107.074708. PubMed DOI PMC

Navarre C, Goffeau A. 2000. Membrane hyperpolarization and salt sensitivity induced by deletion of PMP3, a highly conserved small protein of yeast plasma membrane. EMBO J 19:2515–2524. doi:10.1093/emboj/19.11.2515. PubMed DOI PMC

Miesenbock G, De Angelis DA, Rothman JE. 1998. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 394:192–195. doi:10.1038/28190. PubMed DOI

Anderson TM, Clay MC, Cioffi AG, Diaz KA, Hisao GS, Tuttle MD, Nieuwkoop AJ, Comellas G, Maryum N, Wang S, Uno BE, Wildeman EL, Gonen T, Rienstra CM, Burke MD. 2014. Amphotericin forms an extramembranous and fungicidal sterol sponge. Nat Chem Biol 10:400–406. doi:10.1038/nchembio.1496. PubMed DOI PMC

Young LY, Hull CM, Heitman J. 2003. Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. Antimicrob Agents Chemother 47:2717–2724. doi:10.1128/AAC.47.9.2717-2724.2003. PubMed DOI PMC

Hull CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL. 2012. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B. Antimicrob Agents Chemother 56:4223–4232. doi:10.1128/AAC.06253-11. PubMed DOI PMC

Vandeputte P, Tronchin G, Larcher G, Ernoult E, Berges T, Chabasse D, Bouchara JP. 2008. A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata. Antimicrob Agents Chemother 52:3701–3709. doi:10.1128/Aac.00423-08. PubMed DOI PMC

Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL. 2010. A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B. Antimicrob Agents Chemother 54:3578–3583. doi:10.1128/AAC.00303-10. PubMed DOI PMC

Sharma S, Alfatah M, Bari VK, Rawal Y, Paul S, Ganesan K. 2014. Sphingolipid biosynthetic pathway genes FEN1 and SUR4 modulate amphotericin B resistance. Antimicrob Agents Chemother 58:2409–2414. doi:10.1128/AAC.02130-13. PubMed DOI PMC

Gaskova D, Brodska B, Herman P, Vecer J, Malinsky J, Sigler K, Benada O, Plasek J. 1998. Fluorescent probing of membrane potential in walled cells: diS-C3(3) assay in Saccharomyces cerevisiae. Yeast 14:1189–1197. doi:10.1002/(SICI)1097-0061(19980930)14:13<1189::AID-YEA320>3.3.CO;2-B. PubMed DOI

van den Hazel HB, Pichler H, do Valle Matta MA, Leitner E, Goffeau A, Daum G. 1999. PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs. J Biol Chem 274:1934–1941. doi:10.1074/jbc.274.4.1934. PubMed DOI

Li X, Routt SM, Xie Z, Cui X, Fang M, Kearns MA, Bard M, Kirsch DR, Bankaitis VA. 2000. Identification of a novel family of nonclassic yeast phosphatidylinositol transfer proteins whose function modulates phospholipase D activity and Sec14p-independent cell growth. Mol Biol Cell 11:1989–2005. doi:10.1091/mbc.11.6.1989. PubMed DOI PMC

Desnos-Ollivier M, Dromer F, Dannaoui E. 2008. Detection of caspofungin resistance in Candida spp. by Etest. J Clin Microbiol 46:2389–2392. doi:10.1128/JCM.00053-08. PubMed DOI PMC

Walker LA, Gow NA, Munro CA. 2010. Fungal echinocandin resistance. Fungal Genet Biol 47:117–126. doi:10.1016/j.fgb.2009.09.003. PubMed DOI PMC

Kawahata M, Masaki K, Fujii T, Iefuji H. 2006. Yeast genes involved in response to lactic acid and acetic acid: acidic conditions caused by the organic acids in Saccharomyces cerevisiae cultures induce expression of intracellular metal metabolism genes regulated by Aft1p. FEMS Yeast Res 6:924–936. doi:10.1111/j.1567-1364.2006.00089.x. PubMed DOI

Schmalix WA, Bandlow W. 1994. SWH1 from yeast encodes a candidate nuclear factor containing ankyrin repeats and showing homology to mammalian oxysterol-binding protein. Biochim Biophys Acta 1219:205–210. doi:10.1016/0167-4781(94)90273-9. PubMed DOI

Levine TP, Munro S. 2001. Dual targeting of Osh1p, a yeast homologue of oxysterol-binding protein, to both the Golgi and the nucleus-vacuole junction. Mol Biol Cell 12:1633–1644. doi:10.1091/mbc.12.6.1633. PubMed DOI PMC

Jiang B, Brown JL, Sheraton J, Fortin N, Bussey H. 1994. A new family of yeast genes implicated in ergosterol synthesis is related to the human oxysterol binding protein. Yeast 10:341–353. doi:10.1002/yea.320100307. PubMed DOI

Boyce M, Yuan J. 2006. Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 13:363–373. doi:10.1038/sj.cdd.4401817. PubMed DOI

Johnson LB, Kauffman CA. 2003. Voriconazole: a new triazole antifungal agent. Clın Infect Dıs 36:630–637. doi:10.1086/367933. PubMed DOI

Cuenca-Estrella M. 2014. Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside. Clin Microbiol Infect 20(Suppl 6):54–59. doi:10.1111/1469-0691.12495. PubMed DOI

Branco J, Silva AP, Silva RM, Silva-Dias A, Pina-Vaz C, Butler G, Rodrigues AG, Miranda IM. 2015. Fluconazole and voriconazole resistance in Candida parapsilosis ıs conferred by gain-of-function mutations in MRR1 transcription factor gene. Antimicrob Agents Chemother 59:6629–6633. doi:10.1128/AAC.00842-15. PubMed DOI PMC

Sollner T, Schmidt C, Schmelzer C. 1987. Amplification of the yeast nuclear gene MRS3 confers suppression of a mitochondrial RNA splice defect. Curr Genet 12:497–501. doi:10.1007/BF00419558. PubMed DOI

Muhlenhoff U, Stadler JA, Richhardt N, Seubert A, Eickhorst T, Schweyen RJ, Lill R, Wiesenberger G. 2003. A specific role of the yeast mitochondrial carriers MRS3/4p in mitochondrial iron acquisition under iron-limiting conditions. J Biol Chem 278:40612–40620. doi:10.1074/jbc.M307847200. PubMed DOI

Nyhus KJ, Ozaki LS, Jacobson ES. 2002. Role of mitochondrial carrier protein Mrs3/4 in iron acquisition and oxidative stress resistance of Cryptococcus neoformans. Med Mycol 40:581–591. doi:10.1080/714031152. PubMed DOI

Lovero G, De Giglio O, Rutigliano S, Diella G, Caggiano G, Montagna MT. 2017. In vitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest. J Med Microbiol 66:213–216. doi:10.1099/jmm.0.000402. PubMed DOI PMC

Powderly WG, Kobayashi GS, Herzig GP, Medoff G. 1988. Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med 84:826–832. doi:10.1016/0002-9343(88)90059-9. PubMed DOI

Silver PM, Silver PM, Oliver BG, White TC. 2008. Characterization of caspofungin susceptibilities by broth and agar in Candida albicans clinical isolates with characterized mechanisms of azole resistance. Med Mycol 46:231–239. doi:10.1080/13693780701816557. PubMed DOI PMC

Parker JE, Merkamm M, Manning NJ, Pompon D, Kelly SL, Kelly DE. 2008. Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus. Antimicrob Agents Chemother 52:3597–3603. doi:10.1128/AAC.00517-08. PubMed DOI PMC

Jones T, Federspiel NA, Chibana H, Dungan J, Kalman S, Magee BB, Newport G, Thorstenson YR, Agabian N, Magee PT, Davis RW, Scherer S. 2004. The diploid genome sequence of Candida albicans. Proc Natl Acad Sci U S A 101:7329–7334. doi:10.1073/pnas.0401648101. PubMed DOI PMC

Gietz RD, Schiestl RH, Willems AR, Woods RA. 1995. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 11:355–360. doi:10.1002/yea.320110408. PubMed DOI

Amberg DC, Burke D, Strathern J. 2005. Methods in yeast genetics: a Cold Spring Harbor Laboratory course manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

Arendrup MC, Meletiadis J, Mouton JW, Lagrou K, Hamal P, Guinea J. 2017. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for fermentative yeasts. EUCAST defınıtıve document EDEF 7.3.1 https://www.ncbi.nlm.nih.gov/pubmed/18190574.

Metzenberg RL, Grotelueschen JS. 1992. Disruption of essential genes in Neurospora by RIP. Fungal Genet Newsl 39:37–49.

Alberti S, Gitler AD, Lindquist S. 2007. A suite of Gateway cloning vectors for high-throughput genetic analysis in Saccharomyces cerevisiae. Yeast 24:913–919. doi:10.1002/yea.1502. PubMed DOI PMC

Kodedova M, Sychrova H. 2015. Changes in the sterol composition of the plasma membrane affect membrane potential, salt tolerance and the activity of multidrug resistance pumps in Saccharomyces cerevisiae. PLoS One 10:e0139306. doi:10.1371/journal.pone.0139306. PubMed DOI PMC

Maresova L, Hoskova B, Urbankova E, Chaloupka R, Sychrova H. 2010. New applications of pHluorin-measuring intracellular pH of prototrophic yeasts and determining changes in the buffering capacity of strains with affected potassium homeostasis. Yeast 27:317–25. doi:10.1002/yea.1755. PubMed DOI

Orij R, Postmus J, Ter Beek A, Brul S, Smits GJ. 2009. In vivo measurement of cytosolic and mitochondrial pH using a pH-sensitive GFP derivative in Saccharomyces cerevisiae reveals a relation between intracellular pH and growth. Microbiology 155:268–278. doi:10.1099/mic.0.022038-0. PubMed DOI

Duskova M, Borovikova D, Herynkova P, Rapoport A, Sychrova H. 2015. The role of glycerol transporters in yeast cells in various physiological and stress conditions. FEMS Microbiol Lett 362:1–8. doi:10.1093/femsle/fnu041. PubMed DOI